Cases of Omicron are spreading like wildfire over the globe.
Some nations are already looking to a fourth vaccine dose to help contend with a huge Omicron-driven spike in COVID-19 cases, but early signs suggest repeat vaccination may be a hard sell as beleaguered populations enter their third pandemic year.
Cities across China are imposing tougher restrictions to try to control new outbreaks of COVID-19, with Tianjin battling the highly contagious Omicron variant which has been detected to have been transmitted locally in two other provinces.
The United States reported 1.35 million new coronavirus infections on Monday, according to a Reuters tally, the highest daily total for any country in the world as the spread of the highly contagious Omicron variant showed no signs of slowing.
American shoppers flocked to brick-and-mortar stores this holiday season, with especially strong sales in several states where the rate of full vaccinations against the COVID-19 virus is less than 60%, according to an analysis of Mastercard SpendingPulse holiday sales data.
U.S. banks have been more proactive than other industries in encouraging employees back to the office, but those plans have come under renewed scrutiny due to the rapid spread of the Omicron coronavirus variant.
The U.S. Supreme Court agreed on Wednesday to take up disputes over the Biden administration’s nationwide vaccine-or-testing COVID-19 mandate for large businesses and a separate vaccine requirement for healthcare workers.
Kellogg Co (K.N) and the union representing striking workers at its U.S. breakfast cereal plants have reached a tentative agreement on a new five-year contract that could pave the way for the employees to return to work two days after Christmas.
Australia, despite restrictions on international visitors, became the latest country on Friday to report community transmission of Omicron, a day after the coronavirus variant was found locally in five U.S. states.
As the Trump administration debated whether to declare COVID-19 a national emergency early last year, a little-known U.S. health office issued a public plea to Big Pharma.
Cases of Omicron are spreading like wildfire over the globe.
Some nations are already looking to a fourth vaccine dose to help contend with a huge Omicron-driven spike in COVID-19 cases, but early signs suggest repeat vaccination may be a hard sell as beleaguered populations enter their third pandemic year.
Cities across China are imposing tougher restrictions to try to control new outbreaks of COVID-19, with Tianjin battling the highly contagious Omicron variant which has been detected to have been transmitted locally in two other provinces.
The United States reported 1.35 million new coronavirus infections on Monday, according to a Reuters tally, the highest daily total for any country in the world as the spread of the highly contagious Omicron variant showed no signs of slowing.
American shoppers flocked to brick-and-mortar stores this holiday season, with especially strong sales in several states where the rate of full vaccinations against the COVID-19 virus is less than 60%, according to an analysis of Mastercard SpendingPulse holiday sales data.
U.S. banks have been more proactive than other industries in encouraging employees back to the office, but those plans have come under renewed scrutiny due to the rapid spread of the Omicron coronavirus variant.
The U.S. Supreme Court agreed on Wednesday to take up disputes over the Biden administration’s nationwide vaccine-or-testing COVID-19 mandate for large businesses and a separate vaccine requirement for healthcare workers.
Kellogg Co (K.N) and the union representing striking workers at its U.S. breakfast cereal plants have reached a tentative agreement on a new five-year contract that could pave the way for the employees to return to work two days after Christmas.
Australia, despite restrictions on international visitors, became the latest country on Friday to report community transmission of Omicron, a day after the coronavirus variant was found locally in five U.S. states.
As the Trump administration debated whether to declare COVID-19 a national emergency early last year, a little-known U.S. health office issued a public plea to Big Pharma.
© | All rights reserved.
